Search
for
Sort by
Research 331–360 of 1000+
- Topical use of systemic drugs in dermatology: A comprehensive review
- A comparative analysis of immune privilege in pregnancy and cancer in the context of checkpoint blockade immunotherapy
- Psychoactive drugs and skin
- Drug eruptions in dermatology
- Humanized CXCL12 antibody delays onset and modulates immune response in alopecia areata mice: insights from single-cell RNA sequencing
- Role of skin enzymes in metabolism of topical drugs
- Incidence of adverse cutaneous drug reactions in a Mexican sample: an exploratory study on their association to tumour necrosis factor alpha TNF2 allele
- Metformin: Old Drug, New Therapeutic Potential in the Skin? A Brief Narrative Review
- Therapeutic Application of Microsponges-based Drug Delivery Systems
- Construction of regulatory network for alopecia areata progression and identification of immune monitoring genes based on multiple machine-learning algorithms
- Unlocking Dithranol’s Potential: Advanced Drug Delivery Systems for Improved Pharmacokinetics
- HHV-6A and HHV-6B in Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms
- Early prediction of alopecia areata using machine learning modeling of neuro stress immune signatures from multi datasets
- Platelet Immune Interactions, Lifespan, and Senescence
- Chemotherapy and Cutaneous Drug Reactions
- Antihelminthic Drugs
- Cutaneous drug reactions
- Development of Novel Drug Delivery Systems for the Treatment of Alopecia
- The modern scientific interpretation of ancient wisdom: a review of the phytochemistry and pharmacology of Erzhi Pill and its constituent botanical drugs
- Novel drugs of United States Food and Drug Administration approved in 2024
- Skin bacteriota ameliorates androgenetic alopecia via harmonizing skin immuno inflammatory balance
- Upadacitinib for the Treatment of Systemic Immune Co-Morbidity in One Case: Alopecia Areata, Vitiligo, Ankylosing Spondylitis, and Allergic Rhinitis-Asthma – Multifaceted Control
- Sacituzumab tirumotecan (sac-TMT/MK-2870/SKB264): a novel antibody–drug conjugate in breast cancer
- Immune Microenvironment of Hair Follicles in Tumor Immunotherapy
- Macrophages as central mediators of sympathetic neuro-immune interplay in autoimmunity
- Dissolving microneedles: an advanced approach for transdermal drug delivery
- New Drugs: Dutasteride
- New drugs: Agalsidase beta
- Dermatological drugs, topical agents, and cosmetics
- Cytostatics and immunosuppressive drugs